KR970706300A - E형 간염 파키스탄형 균주의 재조합 단백질 및 이를 이용한 진단방법과 백신(recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines) - Google Patents
E형 간염 파키스탄형 균주의 재조합 단백질 및 이를 이용한 진단방법과 백신(recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines)Info
- Publication number
- KR970706300A KR970706300A KR1019970702198A KR19970702198A KR970706300A KR 970706300 A KR970706300 A KR 970706300A KR 1019970702198 A KR1019970702198 A KR 1019970702198A KR 19970702198 A KR19970702198 A KR 19970702198A KR 970706300 A KR970706300 A KR 970706300A
- Authority
- KR
- South Korea
- Prior art keywords
- hepatitis
- strain
- vaccine
- pakistani strain
- pakistani
- Prior art date
Links
- 201000010284 hepatitis E Diseases 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 208000006454 hepatitis Diseases 0.000 title abstract 2
- 231100000283 hepatitis Toxicity 0.000 title abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 2
- 238000003745 diagnosis Methods 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 241000724675 Hepatitis E virus Species 0.000 abstract 1
- 108700026244 Open Reading Frames Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28123—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/316,765 | 1994-10-03 | ||
US08/316,765 US6706873B1 (en) | 1992-09-18 | 1994-10-03 | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
PCT/US1995/013102 WO1996010580A2 (en) | 1994-10-03 | 1995-10-03 | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020007003415A Division KR100332602B1 (ko) | 1992-09-18 | 1995-10-03 | E형 간염 파키스탄형 균주의 재조합 단백질에 대한 항체 |
KR1020007010531A Division KR100318516B1 (ko) | 1992-09-18 | 1995-10-03 | E형 간염 파키스탄형 균주의 재조합 단백질 및 이를이용한 진단방법과 백신 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970706300A true KR970706300A (ko) | 1997-11-03 |
KR100359526B1 KR100359526B1 (ko) | 2003-02-25 |
Family
ID=23230582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970702198A KR100359526B1 (ko) | 1994-10-03 | 1995-10-03 | E형간염파키스탄형균주의재조합단백질및이를이용한진단방법과백신 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0784631B1 (ko) |
JP (1) | JP3889808B2 (ko) |
KR (1) | KR100359526B1 (ko) |
CN (1) | CN1148450C (ko) |
AT (1) | ATE518879T1 (ko) |
AU (1) | AU712901B2 (ko) |
NO (1) | NO326399B1 (ko) |
NZ (1) | NZ295056A (ko) |
WO (1) | WO1996010580A2 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054567A (en) * | 1997-04-11 | 2000-04-25 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
ATE346087T1 (de) | 1997-07-18 | 2006-12-15 | Us Health | Hepatitis e-virus aus dem schwein und dessen verwendungen |
US6458562B1 (en) | 1998-04-09 | 2002-10-01 | The United States Of America As Represented By The Secretary Of Health And Human Services | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
WO2001057073A2 (en) * | 2000-02-07 | 2001-08-09 | Department Of Science And Technology | Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
CN101367869B (zh) | 2000-09-30 | 2012-12-05 | 北京万泰生物药业股份有限公司 | 用于预防、诊断及治疗戊型肝炎病毒的多肽,及它们作为诊断试剂和疫苗 |
US20040101820A1 (en) * | 2001-06-25 | 2004-05-27 | Kazuaki Takahashi | Polynucleotide probe and primer originating in hepatitis e virus of japanese, chips having the same, kits having the same and method of detecting hepatits e virus using the same |
CN100446813C (zh) * | 2005-06-24 | 2008-12-31 | 东南大学 | 甲型肝炎-戊型肝炎联合疫苗及其制备方法 |
CN112225783B (zh) * | 2020-09-16 | 2021-08-31 | 东莞市朋志生物科技有限公司 | Hcv重组抗原及其突变体 |
CN114957411B (zh) * | 2022-05-25 | 2023-08-18 | 徐州医科大学 | 一种正戊型肝病毒属基因c1型病毒orf2重组蛋白及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0662133B1 (en) * | 1992-09-18 | 2009-11-18 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
CA2179609A1 (en) * | 1993-12-22 | 1995-06-29 | Deborah A. Paul | Monoclonal antibodies against hev orf-2 and methods for using same |
-
1995
- 1995-10-03 KR KR1019970702198A patent/KR100359526B1/ko not_active IP Right Cessation
- 1995-10-03 AT AT95936312T patent/ATE518879T1/de not_active IP Right Cessation
- 1995-10-03 AU AU38309/95A patent/AU712901B2/en not_active Ceased
- 1995-10-03 NZ NZ295056A patent/NZ295056A/xx not_active IP Right Cessation
- 1995-10-03 JP JP51217096A patent/JP3889808B2/ja not_active Expired - Fee Related
- 1995-10-03 EP EP95936312A patent/EP0784631B1/en not_active Expired - Lifetime
- 1995-10-03 WO PCT/US1995/013102 patent/WO1996010580A2/en not_active Application Discontinuation
- 1995-10-03 CN CNB951965484A patent/CN1148450C/zh not_active Expired - Lifetime
-
1997
- 1997-04-03 NO NO19971529A patent/NO326399B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO971529L (no) | 1997-05-26 |
EP0784631A1 (en) | 1997-07-23 |
AU3830995A (en) | 1996-04-26 |
NZ295056A (en) | 1999-06-29 |
JPH11500001A (ja) | 1999-01-06 |
JP3889808B2 (ja) | 2007-03-07 |
CN1168698A (zh) | 1997-12-24 |
KR100359526B1 (ko) | 2003-02-25 |
NO326399B1 (no) | 2008-11-24 |
CN1148450C (zh) | 2004-05-05 |
NO971529D0 (no) | 1997-04-03 |
AU712901B2 (en) | 1999-11-18 |
ATE518879T1 (de) | 2011-08-15 |
WO1996010580A2 (en) | 1996-04-11 |
WO1996010580A3 (en) | 1996-05-23 |
EP0784631B1 (en) | 2011-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994006913A3 (en) | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines | |
Lagging et al. | Immune responses to plasmid DNA encoding the hepatitis C virus core protein | |
DK0610250T3 (da) | Vaccine med porcint reproduktivt respiratorisk syndrom og diagnose heraf | |
WO1991015516A3 (en) | Hepatitis c virus epitopes | |
DE122007000100I1 (de) | Papillomavirus vakzine | |
DE69133599D1 (de) | Enterisch übertragendes non-a/non-b-hepatitis-virus agens und charakteristische epitope von selbigem | |
KR970706300A (ko) | E형 간염 파키스탄형 균주의 재조합 단백질 및 이를 이용한 진단방법과 백신(recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines) | |
ATE310014T1 (de) | Hepatitis b-impfstoff | |
DE69533067D1 (de) | Hepatis e-virus antigene und dessen verwendungen | |
SE9202968D0 (sv) | New peptides, diagnostic antigens, use thereof, vaccines and medicaments | |
WO2002057314A3 (en) | Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes | |
CA2286399A1 (en) | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines | |
NZ309172A (en) | Neutralizing conformational epitopes of chicken anemia virus | |
RU92004487A (ru) | Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |